The U.S. Food and Drug Administration is warning consumers again not to use the ShoulderFlex Massager, imported by King International and sold by various companies, due to serious potential health risks.

The ShoulderFlex Massager is a personal massage device sold in retail stores, catalogs and over the Internet. It is intended to provide users with a deep tissue massage to the neck, shoulders and back area while lying down.

Hair, clothing or jewelry can become entangled in the ShoulderFlex Massager and cause serious injury or even death from strangulation. There have been reports of one death and one near death, due to strangulation, associated with the use of this device.

“The ShoulderFlex Massager poses serious risks. Consumers should stop using this device, health care providers should not recommend it to their patients and businesses should stop distributing and selling the device,” said Steve Silverman, director of the Office of Compliance in the FDA’s Center for Devices and Radiological Health.

King International recalled the ShoulderFlex Massager on Aug. 31, 2011; however, during a recent compliance audit, the FDA found that the company has gone out of business. King International has not followed through with recall procedures; the 800 number established by the firm for this recall is no longer in service; and many of the companies that sell this device are not aware of the recall or did not properly notify customers who purchased the massager.

Because of this failure, the FDA is concerned that consumers may not be aware of the risks posed by the ShoulderFlex Massager and may still be using this dangerous product.

The FDA recommends that customers and consignees safely dispose of the ShoulderFlex Massagers so that the device cannot be used. The massage fingers should be removed and disposed of separately from the device; the power supply should be disposed of separately, as well.

If you suspect a problem with the ShoulderFlex Massager, the FDA encourages you to file a voluntary report through MedWatch, the FDA Safety Information and Adverse Event Reporting program. Prompt reporting of adverse events can help the FDA identify and better understand the risks associated with medical devices.

Share This

• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 

About the author

TP Newswire
To suggest a news story or press release please send an email to newsroom@toonaripost.com.

Related Posts

More Garbage on Your Food Shelves than Your Landfills

How much do you know about the food you eat? Consumers are starting to open their eyes and taking a stand on the blinds the FDA (U.S Food and Drug Administration) and companies like Nestle, Bertoli, General Mills, and Pepperidge...

New Medical Research Released at Alzheimer Conference

Vancouver, Canada -- With FDA approval of a brain amyloid imaging compound in early 2012 and the expected start in 2012 and 2013 of three clinical trials in people with pre-symptomatic Alzheimer's disease, issues around disclosure...

Cord Blood Bank Gives Kickback to Doctors

New York, U.S.A. -- In a recent interview for Fox News, Martin Smithmyer, CEO of Americord Registry, one of the industry's leading cord blood banking companies, said, "Although [Americord] does not pay doctors for making...